Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study.
about
Identification and validation of genes involved in cervical tumourigenesis.Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screening.Optimizing technology for cervical cancer screening in high-resource settings.Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.Early detection of cervical carcinomas: finding an overall approachLooking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy.Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer.Exploiting biospectroscopy as a novel screening tool for cervical cancer: towards a framework to validate its accuracy in a routine clinical setting.The involvement of E6, p53, p16, MDM2 and Gal-3 in the clinical outcome of patients with cervical cancer.Enzyme-linked immunosorbent assay for p16(INK4a) - a new triage test for the detection of cervical intraepithelial neoplasia?Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance.
P2860
Q33825832-037737C7-6AE0-49FB-8756-78521F1F31C2Q33978458-CCE2E9FC-497B-49E5-A6DC-71D8E9877F88Q34588271-208169DC-4ECF-4FFB-9616-9566A1DEF3C9Q36319941-C4A545A8-1B5E-4B5B-9EEC-FA9D44970AEEQ37066141-B8331106-424F-4788-989A-7C85BF42130FQ37188108-6876616A-1E9E-43EE-B17B-BC4BC298DBBAQ37195121-00E898A0-DD50-40F6-9EA2-9EE51C099DC5Q37728983-D73343D6-6CE9-47BD-BF8A-4ACAA09FC914Q38158188-66E6695D-FDFB-4BAD-8F8E-B452842B303CQ47107291-78E50E57-6F9A-4FB2-992D-1451303CB270Q50903696-6CF56CF9-3040-4C7D-86BD-2747D173DC53Q54664307-C78FC23E-530C-4DA8-9843-F16DF028C780
P2860
Evaluation of a new p16(INK4A) ELISA test and a high-risk HPV DNA test for cervical cancer screening: results from proof-of-concept study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Evaluation of a new p16
@nl
Evaluation of a new p16(INK4A) ...... s from proof-of-concept study.
@en
type
label
Evaluation of a new p16
@nl
Evaluation of a new p16(INK4A) ...... s from proof-of-concept study.
@en
prefLabel
Evaluation of a new p16
@nl
Evaluation of a new p16(INK4A) ...... s from proof-of-concept study.
@en
P2093
P356
P1476
Evaluation of a new p16(INK4A) ...... s from proof-of-concept study.
@en
P2093
Akhila Balasubramanian
Anja Reichert
Constance Mao
Laura A Koutsky
Magnus von Knebel Doeberitz
Matthias Herkert
Nancy Kiviat
Ruediger Ridder
P304
P356
10.1002/IJC.22612
P577
2007-06-01T00:00:00Z